{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T16:19:16Z","timestamp":1791044356152,"version":"4.1.0"},"reference-count":17,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,20]],"date-time":"2022-03-20T00:00:00Z","timestamp":1647734400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiology Case Reports"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.radcr.2022.03.082","type":"journal-article","created":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T14:46:50Z","timestamp":1650379610000},"page":"2211-2214","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["18F DCFPyL PSMA avid biopsy proven subcutaneous capillary haemangioma as a malignancy mimic in the setting of biochemical recurrent prostate carcinoma"],"prefix":"10.1016","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6138-9166","authenticated-orcid":false,"given":"Manvinder","family":"Dhillon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5509-8322","authenticated-orcid":false,"given":"Dalveer","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.radcr.2022.03.082_bib0001","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s11307-015-0850-8","article-title":"Initial evaluation of [(18)F]DCFPyL for prostate-specific membrane antigen (PSMA)-targeted pet imaging of prostate cancer","volume":"17","author":"Szabo","year":"2015","journal-title":"Mol Imaging Biol"},{"issue":"1","key":"10.1016\/j.radcr.2022.03.082_bib0002","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1148\/rg.2018170108","article-title":"Prostate-specific membrane antigen PET: clinical utility in prostate cancer, normal patterns, pearls, and pitfalls","volume":"38","author":"Hofman","year":"2018","journal-title":"Radiographics"},{"issue":"6","key":"10.1016\/j.radcr.2022.03.082_bib0003","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"10.1016\/j.radcr.2022.03.082_bib0004","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/jcb.10661","article-title":"Tumor target prostate specific membrane antigen (PSMA) and its regulation in prostate cancer","volume":"91","author":"Ghosh","year":"2004","journal-title":"J Cell Biochem"},{"issue":"5","key":"10.1016\/j.radcr.2022.03.082_bib0005","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/j.juro.2015.12.025","article-title":"Diagnostic efficacy of (68)Gallium-PSMA positron emission tomography compared to conventional imaging for lymph node staging of 130 consecutive patients with intermediate to high risk prostate cancer","volume":"195","author":"Maurer","year":"2016","journal-title":"J Urol"},{"issue":"3","key":"10.1016\/j.radcr.2022.03.082_bib0006","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13063","article-title":"Correlation between PSA kinetics and PSMA-PET in prostate cancer restaging: a meta-analysis","volume":"49","author":"Pereira Mestre","year":"2019","journal-title":"Eur J Clin Invest"},{"issue":"1","key":"10.1016\/j.radcr.2022.03.082_bib0007","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s40644-016-0091-3","article-title":"How we read oncologic FDG PET\/CT","volume":"16","author":"Hofman","year":"2016","journal-title":"Cancer Imaging"},{"issue":"9","key":"10.1016\/j.radcr.2022.03.082_bib0008","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1007\/s00259-017-3712-6","article-title":"Fibrous dysplasia mimicking bone metastasis on (68)GA-PSMA PET\/MRI","volume":"44","author":"De Coster","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"10.1016\/j.radcr.2022.03.082_bib0009","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/1754-9485.12864","article-title":"Unexpected significant findings non-related to prostate cancer identified using combined prostate-specific membrane antigen positron emission tomography\/CT and diagnostic CT scan in primary staging for prostate cancer","volume":"63","author":"McEwan","year":"2019","journal-title":"J Med Imaging Radiat Oncol"},{"issue":"1","key":"10.1016\/j.radcr.2022.03.082_bib0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0210297","article-title":"Overexpression of prostate specific membrane antigen by canine hemangiosarcoma cells provides opportunity for the molecular detection of disease burdens within hemorrhagic body cavity effusions","volume":"14","author":"Dowling","year":"2019","journal-title":"PLOS One"},{"issue":"1","key":"10.1016\/j.radcr.2022.03.082_bib0011","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s40644-020-00300-7","article-title":"Nonprostatic diseases on PSMA PET imaging: a spectrum of benign and malignant findings","volume":"20","author":"de Galiza Barbosa","year":"2020","journal-title":"Cancer Imaging"},{"issue":"3","key":"10.1016\/j.radcr.2022.03.082_bib0012","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/RLU.0000000000002428","article-title":"Splenic hemangioma as a potential pitfall on PSMA-targeted 18F-DCFPyL PET\/CT","volume":"44","author":"Chausse","year":"2019","journal-title":"Clin Nucl Med"},{"issue":"12","key":"10.1016\/j.radcr.2022.03.082_bib0013","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1097\/RLU.0000000000001384","article-title":"Prostate-specific membrane antigen PET\/CT findings for hepatic hemangioma","volume":"41","author":"Bhardwaj","year":"2016","journal-title":"Clin Nucl Med"},{"issue":"5","key":"10.1016\/j.radcr.2022.03.082_bib0014","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1097\/RLU.0000000000001631","article-title":"Vertebral hemangioma mimicking bone metastasis in 68Ga-PSMA ligand PET\/CT","volume":"42","author":"Artigas","year":"2017","journal-title":"Clin Nucl Med"},{"issue":"9","key":"10.1016\/j.radcr.2022.03.082_bib0015","article-title":"Hemangioma of the rib showing a relatively high 18F-FDG uptake: a case report with a literature review","volume":"6","author":"Itabashi","year":"2017","journal-title":"Acta Radiol Open"},{"issue":"10","key":"10.1016\/j.radcr.2022.03.082_bib0016","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1097\/RLU.0000000000002662","article-title":"Incidental detection of splenic hemangioma on 68Ga-PSMA PET\/CT","volume":"44","author":"Sheng","year":"2019","journal-title":"Clin Nucl Med"},{"issue":"4","key":"10.1016\/j.radcr.2022.03.082_bib0017","doi-asserted-by":"crossref","first-page":"e214","DOI":"10.1097\/RLU.0000000000001542","article-title":"Subcutaneous lobular capillary hemangioma on 68Ga-PSMA PET\/CT","volume":"42","author":"Jochumsen","year":"2017","journal-title":"Clin Nucl Med"}],"container-title":["Radiology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1930043322002564?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1930043322002564?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:58:02Z","timestamp":1761825482000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1930043322002564"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":17,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S1930043322002564"],"URL":"https:\/\/doi.org\/10.1016\/j.radcr.2022.03.082","relation":{},"ISSN":["1930-0433"],"issn-type":[{"value":"1930-0433","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"18F DCFPyL PSMA avid biopsy proven subcutaneous capillary haemangioma as a malignancy mimic in the setting of biochemical recurrent prostate carcinoma","name":"articletitle","label":"Article Title"},{"value":"Radiology Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radcr.2022.03.082","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc. on behalf of University of Washington.","name":"copyright","label":"Copyright"}]}}